SANDIMMUN NEORAL caps 100 mg 50 pce

7680526560443 CH-52656 L04AD01 07.15.0.

Active substances:

SANDIMMUN NEORAL caps 100 mg 50 pce
SANDIMMUN NEORAL caps 100 mg 50 pce
1 / 2
Fiches Amavita / Sun Store / Coop Vitality

Details

Product number
5265603
CPT
-
Packaging group
50
Unit
Kapsel(n)
Composition
ciclosporinum 100 mg, ethanolum anhydricum 100 mg, propylenglycolum 100 mg, interesterified corn oil, macrogolglyceroli hydroxystearas 405 mg, E 307, Kapselhülle: titanii dioxidum, glycerolum (85 per centum), propylenglycolum 48.31 mg, gelatina, E 172, Drucktinte: E 120, aluminii chloridum hexahydricum, natrii hydroxidum, propylenglycolum, hypromellosum, pro capsula corresp. ethanolum 12 % V/V.

Articles (1)

Sandimmun Neoral 100 mg, Kapseln
Kapseln
50
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
03/03/2026
Professional SmPC
Français
03/03/2026
Professional SmPC
Italien
03/03/2026
Patient information leaflet
Allemand
16/11/2023
Patient information leaflet
Français
16/11/2023
Patient information leaflet
Italien
16/11/2023

Detailed composition

Substance Quantity Type Category
ciclosporinum
100.0 MG Substance Wirkstoff (Principe actif)
ethanolum anhydricum
100.0 MG Substance HBESI
propylenglycolum
100.0 MG Substance HBESI
interesterified corn oil
- Substance HNIDK
macrogolglyceroli hydroxystearas
405.0 MG Substance HBESI
E 307
- Substance ANTOX
titanii dioxidum
- Substance HNIDK
glycerolum (85 per centum)
- Substance HNIDK
propylenglycolum
48.31 MG Substance HBESI
gelatina
- Substance HNIDK
E 172
- Substance FTODK
E 120
- Substance FIMDK
aluminii chloridum hexahydricum
- Substance HNIDK
natrii hydroxidum
- Substance HNIDK
propylenglycolum
- Substance HBESI
hypromellosum
- Substance HNIDK

Reimbursement information

Public price
CHF 160.50
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 15/03/1995

Authorization holder

Novartis Pharma Schweiz AG

6343 Risch

Authorization information

Swissmedic authorization number
52656
Drug name
Sandimmun Neoral, Kapseln
Galenic form
KAPWE
ATC Code
L04AD01
Authorization status
Z
Dispensation category
B
First authorization
16/05/1994
Authorization expiration date
31/12/9999
IT number
07.15.0.
Domain
Human medicine
Field of application
Immunsuppressivum

Packaging details

Description (FR)
SANDIMMUN NEORAL caps 100 mg 50 pce
Description (DE)
SANDIMMUN NEORAL Kaps 100 mg 50 Stk
Market launch
16/05/1994
Narcotic (BTM)
No

Other packaging sizes

SANDIMMUN NEORAL caps 25 mg 50 pce
50 KAP
View
SANDIMMUN NEORAL caps 50 mg 50 pce
50 KAP
View
SANDIMMUN NEORAL caps 10 mg 60 pce
60 KAP
View
Buy us a coffee Explore the data